Fungal infections in oncology patients: update on epidemiology, prevention, and treatment
KA Marr - Current opinion in oncology, 2010 - journals.lww.com
Fungal infections in oncology patients: update on epidemiolo... : Current Opinion in Oncology
Fungal infections in oncology patients: update on epidemiology, prevention, and treatment …
Fungal infections in oncology patients: update on epidemiology, prevention, and treatment …
Fungal infections in oncology patients: update on epidemiology, prevention, and treatment
KA Marr - Current Opinion in Oncology, 2010 - journals.lww.com
Fungal infections in oncology patients: update on epidemiolo... : Current Opinion in Oncology
Fungal infections in oncology patients: update on epidemiology, prevention, and treatment …
Fungal infections in oncology patients: update on epidemiology, prevention, and treatment …
Fungal infections in oncology patients: update on epidemiology, prevention, and treatment.
KA Marr - Current Opinion in Oncology, 2010 - europepmc.org
Fungal infections in oncology patients: update on epidemiology, prevention, and treatment. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
Fungal infections in oncology patients: update on epidemiology, prevention, and treatment
KA Marr - Current opinion in oncology, 2010 - pubmed.ncbi.nlm.nih.gov
Purpose of review Fungal infections that occur after hematopoietic stem cell transplant and
therapies for hematologic malignancies contribute to poor outcomes. In the recent year …
therapies for hematologic malignancies contribute to poor outcomes. In the recent year …
Fungal infections in oncology patients: Update on epidemiology, prevention, and treatment
KA Marr - Current opinion in oncology, 2010 - pure.johnshopkins.edu
Abstract Purpose of Review: Fungal infections that occur after hematopoietic stem cell
transplant and therapies for hematologic malignancies contribute to poor outcomes. In the …
transplant and therapies for hematologic malignancies contribute to poor outcomes. In the …